Usana Health Sciences Inc (USNA)
43.50
+0.36
(+0.83%)
USD |
NYSE |
Apr 26, 15:59
Usana Health Sciences Revenue (Quarterly): 221.08M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 221.08M |
| September 30, 2023 | 213.36M |
| June 30, 2023 | 238.20M |
| March 31, 2023 | 248.36M |
| December 31, 2022 | 227.96M |
| September 30, 2022 | 233.30M |
| June 30, 2022 | 264.47M |
| March 31, 2022 | 272.87M |
| December 31, 2021 | 267.30M |
| September 30, 2021 | 274.35M |
| June 30, 2021 | 336.84M |
| March 31, 2021 | 307.98M |
| December 31, 2020 | 310.52M |
| September 30, 2020 | 298.51M |
| June 30, 2020 | 258.99M |
| March 31, 2020 | 266.62M |
| December 31, 2019 | 271.30M |
| September 30, 2019 | 260.60M |
| June 30, 2019 | 256.02M |
| March 31, 2019 | 272.99M |
| December 31, 2018 | 299.02M |
| September 30, 2018 | 296.77M |
| June 30, 2018 | 301.46M |
| March 31, 2018 | 292.00M |
| December 31, 2017 | 273.11M |
| Date | Value |
|---|---|
| September 30, 2017 | 261.76M |
| June 30, 2017 | 257.06M |
| March 31, 2017 | 255.32M |
| December 31, 2016 | 252.90M |
| September 30, 2016 | 254.22M |
| June 30, 2016 | 258.51M |
| March 31, 2016 | 240.45M |
| December 31, 2015 | 232.58M |
| September 30, 2015 | 233.29M |
| June 30, 2015 | 233.24M |
| March 31, 2015 | 219.38M |
| December 31, 2014 | 227.87M |
| September 30, 2014 | 191.94M |
| June 30, 2014 | 188.26M |
| March 31, 2014 | 182.40M |
| December 31, 2013 | 186.27M |
| September 30, 2013 | 173.69M |
| June 30, 2013 | 189.14M |
| March 31, 2013 | 169.08M |
| December 31, 2012 | 168.53M |
| September 30, 2012 | 165.18M |
| June 30, 2012 | 160.90M |
| March 31, 2012 | 154.12M |
| December 31, 2011 | 145.95M |
| September 30, 2011 | 143.50M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
213.36M
Minimum
Sep 2023
336.84M
Maximum
Jun 2021
264.66M
Average
264.47M
Median
Jun 2022
Revenue (Quarterly) Benchmarks
| The Hain Celestial Group Inc | 454.10M |
| Acme United Corp | 44.96M |
| Bridgford Foods Corp | 54.84M |
| Better Choice Co Inc | 5.702M |
| Laird Superfood Inc | 9.207M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 16.77M |
| Total Expenses (Quarterly) | 196.86M |
| EPS Diluted (Quarterly) | 0.87 |
| Enterprise Value | 500.40M |
| Gross Profit Margin (Quarterly) | 80.86% |
| Profit Margin (Quarterly) | 7.58% |
| Earnings Yield | 7.59% |
| Operating Earnings Yield | 11.06% |
| Normalized Earnings Yield | 7.586 |